固有再生组:利用间充质微环境和工程化细胞毒性杀伤细胞进行实体瘤免疫治疗
The innate regenerome: Harnessing mesenchymal niches and engineered cytotoxic killers for solid tumor immunotherapy.
60.9分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
The innate regenerome: Harnessing mesenchymal niches and engineered cytotoxic killers for solid tumor immunotherapy.
Lipid nanoparticle mediated delivery of Anti-CD19 CAR mRNA to umbilical cord blood NK cells for targeting CD19⁺ primary B-ALL cells.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。